financetom
Business
financetom
/
Business
/
Pottery Barn owner Williams-Sonoma slightly beats Q3 revenue estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pottery Barn owner Williams-Sonoma slightly beats Q3 revenue estimates
Nov 19, 2025 7:08 AM

Overview

* Williams-Sonoma ( WSM ) Q3 revenue slightly beats analyst expectations, with a 4% comp brand revenue growth

* Adjusted EPS for Q3 beats consensus, reflecting strong operational performance

* Company announced new $1 bln stock repurchase authorization, indicating confidence in future growth

Outlook

* Williams-Sonoma ( WSM ) raises fiscal 2025 operating margin guidance to 17.8% to 18.1%

* Company expects fiscal 2025 net revenue growth of 0.5% to 3.5%

* Williams-Sonoma ( WSM ) anticipates fiscal 2025 interest income of approximately $35 mln

Result Drivers

* COMPARABLE BRAND REVENUE - Q3 comparable brand revenue increased by 4%, with positive comps across all brands

* OPERATING MARGIN - Operating margin expanded to 17.0%, driven by higher merchandise margins and supply chain efficiencies

* LIQUIDITY AND RETURNS - Strong liquidity position enabled $347 mln in returns to stockholders through stock repurchases and dividends

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Slight $1.88 $1.87

Revenue Beat* bln bln (16

Analysts

)

Q3 EPS Beat $1.96 $1.87

(19

Analysts

)

Q3 Net $241.59

Income mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 15 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the home furnishings retailers peer group is "buy"

* Wall Street's median 12-month price target for Williams-Sonoma Inc ( WSM ) is $208.50, about 13.3% above its November 18 closing price of $180.75

* The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 21 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved